Tenderwize
Wróć do wyszukiwania

Open House Biologics Discount Agreements 2026 - Epoetin theta

Techniker Krankenkasse·Hamburg, Germany·Deadline Jun 30, 2028 · 675 days left·Open·Supplies
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 16 Epoetin theta

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

30 / 100

Czynniki ryzyka

No guaranteed turnover; actual demand depends on prescriptions and market share.

Requirement for qualified electronic signature or original signed copy may cause delays.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Jun 2028
  • Conclusion of discount agreements for Epoetin theta
  • Non-exclusive framework of uniform conditions
Pokaż pełne podsumowanie

Open House procedure by Techniker Krankenkasse and associated health insurers to conclude discount agreements (Rabattverträge) for the active substance Epoetin theta. All eligible pharmaceutical entrepreneurs can join at any time during the contract period (July 1, 2026 to June 30, 2028). No exclusivity, no individual negotiations, uniform conditions. The notice clarifies this is not a public procurement contract under EU Directive 2014/24/EU.

Ryzyka

No guaranteed turnover; actual demand depends on prescriptions and market share.

Requirement for qualified electronic signature or original signed copy may cause delays.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG
  • Valid marketing authorization for the offered medicinal product
  • Seat in Germany, EU, or EEA

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria are applied; contracts are concluded with all eligible participants.

Zamawiający

Lokalizacja

Hamburg, DEU

Identyfikator

992-80116-93

Działalność

Health

Części (1)

LOT-0001

Open House Biologics Discount Agreements 2026 - Epoetin theta

Conclusion of discount agreements for the active substance Epoetin theta under § 130a Abs. 8 SGB V. Open to all eligible pharmaceutical entrepreneurs throughout the contract period.

SuppliesEU fundedElectronic submission

Lokalizacja

DE600, Germany

Czas trwania

Jun 2026 - Jun 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria are applied; contracts are concluded with all eligible participants.

Termin

Deadline Jun 30, 2028

Szczegóły zamówienia

Data publikacji
18 May 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
342625-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3